A Dosimetric Comparison of Volumetric-Modulated Arc Therapy to Intensity-Modulated Radiation Therapy in the Treatment of Locally Advanced Rectal Carcinoma

Document Type : Original Paper


1 Consultant of Radiation Oncology, National Cancer Institute, Cairo University, Egypt King Fahad Specialist Hospital, Dammam, Saudi Arabia

2 Assistant Professor of medical physics, Faculty of Medicine, Menofiya University, Egypt Consultant of radiation oncology Physics, King Fahad Specialist Hospital, Dammam, Saudi Arabia

3 Medical Physicist (Radiation Oncology Physics),Radiation Oncology Department, Medical Physics Unit, King Fahad Specialist Hospital, Dammam, Saudi Arabia

4 Radiation Therapist,King Fahad Specialist Hospital, Dammam, Saudi Arabia


Introduction: The study was conducted to compare volumetric-modulated arc therapy (VMAT) with intensity-modulated radiation therapy (IMRT) in patients with locally advanced rectal cancer (LARC).
Material and Methods: Ten computed tomography (CT) scans were selected and for each CT scan, two plans were calculated (IMRT and VMAT). The average cumulative dose-volume histograms of VMAT plans for the planning target volumes (PTVs), organs at risk (OARs), and normal tissues were calculated and compared with those reported for the corresponding IMRT technique.
Results: Target coverage was equivalent for both techniques. For primary PTV, the average homogeneity index (HI) of IMRT was significantly lower than the VMAT plans (0.10±0.04 vs. 0.11±0.03; p <0.0001). The average conformity index (CI) values for IMRT and VMAT were 1.21 and 1.12, respectively, with a nonsignificant trend for better results with VMAT (p =0.1). For the PTV boost, there was a nonsignificant trend for better results with VMAT in average HI and CI. The VMAT was superior to IMRT in OAR sparing. For monitor units (MUs), VMAT plans required 70% less MUs than IMRT.
Conclusion: For LARC patients, VMAT was able to deliver treatment plans dosimetrically equivalent to IMRT in terms of PTV coverage. The VMAT provided better OAR sparing and significant reduction of MUs in comparison to IMRT.


Main Subjects


    1. Lee EH, Lee HY, Choi KS, Jun JK, Park EC, Lee JS. Trends in cancer screening rates among Korean men and women: results from the Korean National Cancer Screening Survey (KNCSS), 2004–2010. Cancer Res Treat. 2011; 43(3):141–7.
    2. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray, F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017; 66:683-91.
    3. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl J Med. 2004; 351:1731–40.
    4. Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, et al. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011; 6:63.
    5. Zhao J, Hu W, Cai G, Wang J, Xie J, Peng, J et al. Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost. Oncotarget. 2016;7(5):6345-51.
    6. Ng SY, Colborn KL, Cambridge L, Hajj C, Yang TJ, Wu AJ, et al. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer. Radiother Oncol. 2016;121:252-7.
    7. Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson MD. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2012; 82(5):1981-7.
    8. Wang JF, Li H, Xiong H, Huang H, Zou YM. Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer. J Huazhong Univ Sci Technolog Med Sci. 2016;36(5):741-6.
    9. Shang J, Kong W, Wang YY, Ding Z, Yan G, Zhe H. VMAT planning study inrectal cancer patients. Radiat Oncol. 2014; 9:219.
    10. International Commission on Radiation Units and Measurements: Prescribing, recording and reporting photon beam therapy ICRU report 62. Bethesda, MD: International Commission on Radiation Units and Measurements. 1999.
    11. Dröge LH, Weber HE, Guhlich M, Leu M, Conradi LC, Gaedcke J, et al. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy. BMC Cancer. 2015;15;750-8.
    12. Duthoy W, De Gersem W, Vergote K, Boterberg K, Derie C, Smeets P, et al. Clinical implementation of intensity modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys. 2004; 60:794–806.
    13. Cilla S, Caravatta L, Picardi V, Sabatino D, Machhia G, Digesu C, et al. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer. Clin Oncol (R Coll Radiol). 2012; 24(4):261–8.
    14. Richetti A, Fogliata A, Clivio A, Nicolini G, Pesce G, Salati E, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol. 2010; 5:14.
    15. Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002; 52:176–83.
    16.  Tho LM, Glegg M, Paterson J, Yap C, Macleod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66: 505–13.
    17.  Robertson JM, Lockman D, Yan D, Wallace M. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70:413–18.
    18. Wolff HA, Wagner DM, Conradi LC, Nennies S, Ghadimi M, Hess CF, et al. Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: A planning study with clinical implications. Radiother Oncol. 2012; 102:30–7.      
    19. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009; 74(3):824–30.
    20. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol. 2008; 86:4–13.
    21. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer. 2007; 7:949–60.
    22. Wang JZ, Li XA, D’Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumour control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2003; 57:543–52.
    23. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 1988; 27:131–46.
    24. Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumour sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007; 68:654–61.
    25. Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, Mageras G. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys. 2010; 76:1456–62.
Volume 17, Issue 6
November and December 2020
Pages 374-379
  • Receive Date: 14 September 2019
  • Revise Date: 04 December 2019
  • Accept Date: 12 December 2019
  • First Publish Date: 01 November 2020